It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies have emerged in recent years on a mission to simplify production for the ...

As cell therapies scale, developers face a choice: redesign processes for all-in-one systems or manage complex bespoke workflows. A third path is emerging: flexible protocols that enable automation ...

Recently, Charles River Laboratories—a provider of products and services for drug research and development—presented a webinar about starting material for manufacturing cell therapies. Scott R. Burger ...

Streamlining cell and gene therapy workflows with precise serological pipetting Cell and gene therapies are transforming the ...